Vertex Pharmaceuticals

Listing Websites about Vertex Pharmaceuticals

Filter Type:

Vertex Pharmaceuticals

(1 days ago) Oops! Something went wrong, please try again later.Add hoursAdd photosOops! Something went wrong, please try again later.WebsiteDirectionsContact usOops! Something went wrong, please try again later.Suggest an edit · Your business? Claim nowVertex Pharmaceuticals Homehttps://www.vrtx.comWebLearn More. Vertex announces global regulatory submissions for sickle cell disease and beta thalassemia. Learn more. Vertex partners with U.S. basketball Hall-of-Famer …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Vertex Pharmaceuticals Our Company

(3 days ago) WebWe are Vertex. We strike at the core of serious diseases to change people’s lives. Bringing together the brightest minds, investing in science and taking smart risks, we go all in. For …

Url: Visit Now

Category:  Health Detail Drugs


Vertex Pharmaceuticals - Wikipedia

(2 days ago) OverviewHistoryMedicinesCEO compensationPricing in the UKVenture philanthropySee alsoExternal linksVertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, near Oxford, England.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Vertex Pharmaceuticals VRTX Stock Price, Company …

(6 days ago) WebThe company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA. Vertex Pharmaceuticals Company Stats. …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Vertex Pharmaceuticals Incorporated (VRTX) - Yahoo!

(6 days ago) WebFind the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


VRTX Stock Price Vertex Pharmaceuticals Inc. Stock Quote (U.S

(8 days ago) WebVertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock …

(4 days ago) Web12 hours ago · Vertex Pharmaceuticals' (NASDAQ:VRTX) stock up by 9.9% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Vertex Pharmaceuticals: Buy at the High? The Motley Fool

(1 days ago) WebVertex Pharmaceuticals (VRTX-1.17%) has a lot going on these days. The biotech company is developing two candidates that could make it even stronger in the …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Is It Too Late to Buy Vertex Pharmaceuticals Stock?

(3 days ago) Web2 days ago · Take Vertex Pharmaceuticals (VRTX 1.85%), a biotech that has delivered market-beating returns over the past decade. The drugmaker is still at it even amid the market downturn and currently sits

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Vertex Pharmaceuticals - VRTX Stock Forecast, Price & News

(6 days ago) Web17 brokerages have issued 1 year price targets for Vertex Pharmaceuticals' shares. Their VRTX share price forecasts range from $222.00 to $365.00. On average, they predict the company's stock price to reach $305.33 in the next twelve months. This suggests that the stock has a possible downside of 3.9%.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Vertex Pharmaceuticals The Science of Possibility

(9 days ago) WebSince 2000, Vertex has invested more than $11B into scientific innovation. Cystic fibrosis is a rare, life-shortening genetic disease caused by mutations of the cystic fibrosis …

Url: Visit Now

Category:  Health Detail Drugs


Vertex Pharmaceuticals Reaches Analyst Target Price Nasdaq

(5 days ago) WebIn recent trading, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) have crossed above the average analyst 12-month target price of $312.63, changing hands for $317.58/share. When a stock

Url: Visit Now

Category:  Pharmaceutical Detail Drugs